NEW YORK/WASHINGTON (Reuters) – A suspected leader of the attack on the U.S. compound in Benghazi, Libya, captured by U.S. forces and spirited out of the country, can expect to move quickly through the initial steps of the criminal justice system within hours of arriving on American soil.
Seized in a raid last Sunday, Libyan militant Ahmed Abu Khatallah is the suspected leader of a group implicated in the 2012 attack on a U.S. diplomatic compound and CIA base in Benghazi.
NEW YORK (Reuters) – A U.S. appeals court on Friday revived a lawsuit by the NFL Players’ Association accusing the National Football League of unlawfully colluding to cap salaries in 2010.
In a unanimous ruling, a three-judge panel from a federal appeals court based in St. Louis said the association could move forward with the lawsuit in a lower federal court.
NEW YORK, June 5 (Reuters) – Lawyers at General Motors Co
came under withering criticism in an internal company
report on Thursday and at least two of them were fired, but the
company’s general counsel, a key adviser to CEO Mary Barra, was
expressly asked by the board to keep his post.
The report by GM’s outside counsel found that while in-house
company lawyers were warned in meetings and documents about an
ignition-switch defect that has since been tied to 13 deaths,
they ignored or did not understand the warnings and never raised
them with their boss, General Counsel Michael Millikin.
NEW YORK/DETROIT (Reuters) – The top lawyer at General Motors Co (GM.N: Quote, Profile, Research, Stock Buzz) has survived the automaker’s struggles over an ignition-switch defect, as a rash of firings announced on Thursday touched the corporate legal department he oversees.
Michael Millikin, GM’s general counsel since 2009 and a key counselor to Chief Executive Mary Barra, was still on the job, Barra said in response to a reporter’s question at an event in Warren, Michigan.
May 23 (Reuters) – Troubled U.S. lobbying giant Patton Boggs
avoided a financial cliff on Friday when a larger law firm
agreed to acquire many of its partners and its name, which for
decades was synonymous with influence in Washington, D.C.
The acquisition of Patton Boggs by Squire Sanders, a firm
with roots in Ohio, followed furious talks that a day earlier
appeared on the verge of collapse.
By Casey Sullivan and David Ingram
(Reuters) – The law firms Squire Sanders and Patton Boggs said on Friday they had agreed to combine, striking a deal that is expected to save Patton Boggs from growing financial strain.
In a news release, the two firms said they would begin operating under the name Squire Patton Boggs effective June 1.
WASHINGTON (Reuters) – Justice Samuel Alito is no longer recusing himself from two upcoming U.S. Supreme Court business cases, including a challenge by broadcast networks to online TV startup Aereo Inc.
In two online docket entries that were updated on Wednesday, the court said Alito would allow himself to participate in the Aereo case and a product-labeling dispute brought against Coca-Cola Co by fellow beverage-maker POM Wonderful LLC.
WASHINGTON (Reuters) – A U.S. judge sentenced a former State Department analyst on Wednesday to 13 months in prison for sharing classified information about North Korea with a reporter in 2009 without authorization.
Stephen Kim, 46, told U.S. District Judge Colleen Kollar-Kotelly at a hearing that he took full responsibility for violating a law designed to protect national defense information and that he planned to restart his life after prison.
WASHINGTON (Reuters) – An Idaho man who fired a rifle at the White House in 2011 was sentenced on Monday to 25 years in prison, lawyers said.
Oscar Ramiro Ortega-Hernandez, 23, of Idaho Falls, Idaho, was sentenced in U.S. District Court in Washington, D.C., for firing at least eight rounds with a semi-automatic rifle.
WASHINGTON, March 28 (Reuters) – The U.S. Federal Trade
Commission seeks a settlement of $1 billion or more from
pharmaceutical companies it has sued for delaying the sale of
cheaper medicines after patents on brand-name drugs may have
expired, an FTC official told a legal conference on Friday.
The antitrust agency alleges that the way drugmakers settle
patent-related lawsuits hurts consumers by making drugs more
expensive. In the settlements, makers of brand-name drugs pay
millions of dollars to generics companies while they delay
putting their products on the U.S. market.